Association between augmented enteral protein and muscle mass attenuation in critically ill patients: A sub‐study of a cluster randomized crossover trial
Journal of Parenteral and Enteral Nutrition · 21.10.2026
DOI: 10.1002/jpen.70158 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parenteral and Enteral Nutrition, online erschienen am 21.10.2026. Verfasst von Matthew J Summers und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The primary trial was funded by a National Health and Medical Research Council Medical Research Future Fund rare cancers, rare disease and unmet need streams g….
Abstract (Originalsprache)
Background
Critically ill patients experience muscle wasting, impacting recovery. The associations between augmented enteral protein and muscle mass, strength, physical function, and quality of life are uncertain.
Methods
We performed a sub‐study in adult TARGET Protein participants from two sites between 23/11/2022‐23/05/2023. Our exposure of interest was enteral formula with augmented protein (100 g protein/L) and comparator usual protein formula (63 g protein/L), which were isocaloric. Our primary outcome was the change in quadriceps muscle layer thickness from Days 1 to 7, determined by ultrasonography and compared between groups. Our secondary outcomes were group differences in handgrip strength, change in physical function, and quality of life. Data are numbers (%), mean (standard deviation), and differences with 95% confidence intervals (CI).
Results
Seventy‐two patients were included (augmented protein n = 46, 61 (16)y, 65% male; usual protein n = 26, 56 (16)y, 46% male), 56 had primary outcome data (augmented protein n = 35; usual protein n = 21). Delivered protein was higher with augmented protein (1.2 (0.4) vs 0.8 (0.3) g/kg/day). Quadriceps muscle layer thickness decreased in both groups, with change from Days 1 to 7 similar (0.01 cm; 95% CI, −0.27, 0.28; P = 0.970). Left handgrip strength at ICU discharge and quality of life at Day 90 were similar. Augmented protein was associated with greater right handgrip strength at ICU discharge (6.23; 95% CI, 0.67, 11.79) and was associated with greater decline in physical function at ICU discharge (−15.00; 95% CI, −19.75, −10.25), but not at Day 90.
Conclusion
No clear difference was detected in quadriceps muscle layer attenuation over 7 days between augmented enteral protein and usual protein. Trial Registration Australian New Zealand Clinical Trials Registry identifier: ACTRN12622001465741.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, College of Health, Adelaide University, Adelaide, South Australia, Australia.
- Intensive Care Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
- Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand.
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
- Methods and Implementation Support for Clinical and Health (MISCH) Research Hub, Faculty of Medicine, Dentistry, and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia.
- Medical Research Institute of New Zealand, Wellington, New Zealand.
ORCID-Profile: Matthew J Summers, Adam M Deane, Lee-Anne S Chapple
Förderung
- The primary trial was funded by a National Health and Medical Research Council Medical Research Future Fund rare cancers, rare disease and unmet need streams g…
Zitieren
APA
Summers, M. J., Viner Smith, E., Hadley-Brown, K., Karahalios, A., D'Arcy, T., Asser, I. E., Plummer, M. P., Follett, T., Young, P., Deane, A. M., & Chapple, L. S. (2026). Association between augmented enteral protein and muscle mass attenuation in critically ill patients: A sub‐study of a cluster randomized crossover trial. Journal of Parenteral and Enteral Nutrition. https://doi.org/10.1002/jpen.70158
Vancouver
Summers MJ, Viner Smith E, Hadley-Brown K, Karahalios A, D'Arcy T, Asser IE, et al. Association between augmented enteral protein and muscle mass attenuation in critically ill patients: A sub‐study of a cluster randomized crossover trial. Journal of Parenteral and Enteral Nutrition. 2026. doi:10.1002/jpen.70158
BibTeX
@article{Summers2026,
author = {Summers, Matthew J and Viner Smith, Elizabeth and Hadley-Brown, Kate and Karahalios, Amalia and D'Arcy, Tara and Asser, Imogen E and Plummer, Mark P and Follett, Terri and Young, Paul and Deane, Adam M and Chapple, Lee-Anne S},
title = {Association between augmented enteral protein and muscle mass attenuation in critically ill patients: A sub‐study of a cluster randomized crossover trial},
journal = {Journal of Parenteral and Enteral Nutrition},
year = {2026},
doi = {10.1002/jpen.70158}
}
EUVIMED